Trials / Completed
CompletedNCT01539629
ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0
Evaluation of Left Ventricular Autothreshold
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This 3rd phase of the ELEVATE study. The study is collecting data from an implanted CRT-D device to evaluate a new feature for future heart failure devices.
Detailed description
ELEVATE 3.0 is an acute, prospective, multicenter feasibility study which is randomized within a patient test sequence and pulse width. The study is designed to characterize the performance of LVAT (Left Ventricular Authothreshold) feature.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiac pacing | Cadiac pacing via a pulse generator and implaned intracardiac leads. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-06-01
- Completion
- 2012-11-01
- First posted
- 2012-02-27
- Last updated
- 2012-12-05
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01539629. Inclusion in this directory is not an endorsement.